The present invention relates to {HEAD ~ compounds} and pharmaceutical compositions which are proteonaimetic and to methods for inhibiting the interaction of an alpha helical protein with {TAIL ~ another protein} or binding site 
The present invention relates to { HEAD ~ compounds } and pharmaceutical compositions which are proteonaimetic and to methods for inhibiting the interaction of an alpha helical protein with { TAIL ~ another protein } or binding site
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH